Concepedia

Publication | Closed Access

Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial

54

Citations

17

References

2009

Year

References

YearCitations

Page 1